Releases Saturday 14 July 2001
No 7304 Volume 323

Please remember to credit the BMJ as source when publicising an
article and to tell your readers that they can read its full text on the
journal's web site (http://bmj.com).

If your story is posted on a website please include a link back to
the source BMJ article (URL's are given under titles).



(1)  OXYGEN TREATMENT FOR SVERE ASTHMA
COULD SAVE LIVES

(2)  H Pylori TEST NOT ALWAYS USEFUL FOR
DIAGNOSING ULCERS

(3)  UNIQUE NEW SCORING SYSTEM CAN PREDICT
RISK OF DEATH FROM CARDIOVASCULAR
DISEASE


 

(1)  OXYGEN TREATMENT FOR SVERE ASTHMA
COULD SAVE LIVES

(Oxygen treatment for acute severe asthma)
http://bmj.com/cgi/content/full/323/7304/98

Asthmatic patients are still dying during severe attacks, yet
making oxygen available in every general practice to treat
patients with a life threatening asthma attack could save lives,
concludes a study in this week's BMJ. The authors urge the
British Thoracic Society to review this issue when it updates
its asthma guidelines.

A research team in London reviewed 11 studies of acute
severe asthma in both children and adults. Despite some
limitations, these studies show that hypoxaemia (an inadequate
supply of oxygen to the tissues) is an important cause of death
during a severe asthma attack. Some studies also suggest that
treatment with air during severe attacks may worsen
hypoxaemia.

The British Thoracic Society's guidelines advise oxygen as a
first line treatment in hospital for all patients with acute severe
asthma. In general practice however, the guidelines imply that
general practitioners should be prepared to treat acute asthma
of all severities but do not advise the use of oxygen for
children or insist on its use in adults. This may be because
many general practices do not keep an oxygen cylinder.

Oxygen should be the first treatment for acute severe asthma
wherever the patient happens to be, say the authors. Given
that most asthma deaths occur in the community, oxygen
should be available in every general practice. Patients with
severe disease could also be provided with oxygen cylinders
for emergency use at home, they conclude.

Contact:

Mark Rolans, Consultant, Birmingham Heartlands Hospital,
Birmingham, UK
 

(2)  H Pylori TEST NOT ALWAYS USEFUL FOR
DIAGNOSING ULCERS

(Testing for Helicobacter pylori in
dyspeptic patients suspected of peptic ulcer disease in primary
care: cross sectional study)
http://bmj.com/cgi/content/full/323/7304/71

Routine testing for H pylori infection in patients consulting their
general practitioner with indigestion (dyspepsia) does not aid
the diagnosis of peptic ulcers, concludes a study from the
Netherlands in this week's BMJ.

Testing is useful only in patients at high risk of peptic ulcer
disease, and these patients can be identified by asking three
simple questions during the consultation, report the authors.

Between June 1996 and January 2000, general practitioners in
Utrecht recorded the age, sex, medical history and smoking
behaviour of 565 patients suffering with dyspeptic symptoms
of at least two weeks' duration. All patients were subsequently
tested for H pylori infection.

In all patients, smoking, pain on an empty stomach, and a
history of peptic ulcer were independent predictors of peptic
ulcer disease. Adding the H pylori test did not provide any
additional diagnostic information. However, in a group of
patients at high risk, identified by means of a simple scoring
system, the predicted presence of peptic ulcer increased from
16% to 26% after a positive H pylori test.

Despite some study limitations, the authors conclude that
adding testing for H pylori infection to history taking might be
useful only in patients at high risk of having peptic ulcer
disease. It would avoid invasive examinations in some patients
and lead to more accurate treatment of peptic ulcer disease in
most patients.

Contact:

Catherine F Weijnen, Clinical Research Fellow, University
Medical Center Utrecht, Netherlands
Email: c.f.weijnen{at}med.uu.nl
 

(3)  UNIQUE NEW SCORING SYSTEM CAN PREDICT
RISK OF DEATH FROM CARDIOVASCULAR
DISEASE

(A score for predicting risk of death from cardiovascular
disease in adults with raised blood pressure, based on
individual patient data from randomised controlled trials)
http://bmj.com/cgi/content/full/323/7304/75

A unique new scoring system for assessing a patient's risk of
death from cardiovascular disease is revealed in this week's
BMJ. The score will help physicians determine a patient's
need for drugs to reduce blood pressure (antihypertensive
drugs) and other strategies for improving cardiovascular
health.

The score is based on information from eight large trials of
antihypertensive drugs, involving over 47,000 men and women
across Europe and North America. It uses 11 risk factors,
including age, sex, systolic blood pressure and total
cholesterol levels, smoking, and diabetes, to quantify an adult's
risk of death from cardiovascular heart disease. Points are
added for each factor according to its association with risk
and patients can be classified simply as high or low risk
compared with others of the same age and sex.

Age is a particularly strong risk factor ? a woman aged 60-64
has 23 extra points compared with a woman aged 35-39. Sex
is also important, with men having 12 extra points. Smoking
attributed more in women and younger age groups. In women,
cholesterol levels mattered less than in men, whereas diabetes
had more of an effect.

As the score is based on a large group of patients in controlled
trials of antihypertensive drugs, it has wide applicability in
general practices and hypertension clinics, providing a simple
means of quantifying a patient's risk of cardiovascular disease
based on what should be routinely available information,
conclude the authors.

Contact:

Francois Gueyffier, Physician, Service de
Pharmacologie Clinique, Lyon, France
 


FOR ACCREDITED JOURNALISTS

Embargoed press releases and articles are available from:

Public Affairs Division
BMA House
Tavistock Square
London WC1H 9JR
(contact: pressoffice{at}bma.org.uk)
 
and from:

the EurekAlert website, run by the American Association for the
Advancement of Science
(http://www.eurekalert.org)
 




Access jobs at BMJ Careers
Whats new online at Student 

BMJ